Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Edwards Lifesciences Corp banner

Edwards Lifesciences Corp
NYSE:EW

Watchlist Manager
Edwards Lifesciences Corp Logo
Edwards Lifesciences Corp
NYSE:EW
Watchlist
Price: 88.41 USD -0.97% Market Closed
Market Cap: $50.9B
Write Note Create Alert Ask AI

Wall St Price Targets

EW Price Targets Summary
Edwards Lifesciences Corp

Wall Street analysts forecast EW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EW is 103.02 USD with a low forecast of 85.85 USD and a high forecast of 115.5 USD.

EW Lowest Forecast
Wall Street Target
$85.85
-3% Downside
EW Average Forecast
Wall Street Target
$103.02
17% Upside
EW Highest Forecast
Wall Street Target
$115.5
31% Upside
Lowest Forecast
Price Target
85.85 USD
3% Downside
Average Forecast
Price Target
103.02 USD
17% Upside
Highest Forecast
Price Target
115.5 USD
31% Upside
Edwards Lifesciences Corp Competitors:
Price Targets

Revenue
Forecast

9% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
9% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.

What are analyst estimates?

Gross Profit
Forecast

10% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
10% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.

What are analyst estimates?

Operating Income
Forecast

11% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
11% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.

What are analyst estimates?

Pre-Tax Income
Forecast

10% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
10% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.

What are analyst estimates?

Net Income
Forecast

11% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
11% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.

What are analyst estimates?

Continue EW Research

Summary
EW intrinsic value, competitors valuation, and company profile.
DCF Valuation
EW stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EW stock valuation using valuation multiples.
Wall St Estimates
EW price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EW stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Edwards Lifesciences Corp listings:
F • EUR
EWL
 BMV • MXN
EW
 SWB • EUR
EWL
 XETRA • EUR
EWL
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EW's stock price target?
Price Target
103.02 USD

According to Wall Street analysts, the average 1-year price target for EW is 103.02 USD with a low forecast of 85.85 USD and a high forecast of 115.5 USD.

What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.

What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.

What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.

What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.

What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.